Dominick C. Colangelo has been leading Vericel Corporation as President and CEO since March 2013. With an MBA from Harvard Business School, he brings strong business acumen to the biotechnology sector. Under his leadership, Vericel has made significant strides, focusing...

Dominick C. Colangelo has been leading Vericel Corporation as President and CEO since March 2013. With an MBA from Harvard Business School, he brings strong business acumen to the biotechnology sector. Under his leadership, Vericel has made significant strides, focusing on innovative cell therapy products. For instance, he successfully navigated the company to surpass key revenue targets and achieve a remarkable total shareholder return of 219% in 2018. Interestingly, his annual compensation reflected the company's performance, with a major boost in 2018 tied to a strong achievement of corporate goals. Notably, as part of his employment agreement, he was granted stock options to align his interests with the company's growth. This means he's not just leading from the front, but also has financial skin in the game. His ability to attract investment and expand product offerings has been crucial for Vericel's success in a competitive landscape.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

V

Dominick C. Colangelo

CEO of Vericel

Education

B.S.B.A. in Accounting, Magna Cum Laude, from the State University of New York at Buffalo and a J.D. degree, with Honors, from the Duke University School of Law.

Field of Expertise

Business & Management

Sector of Economy

Healthcare

CEO of Vericel for

12 years 6 months (Jan 2013 - Present)

Previous Experience

Executive management and corporate development experience in the biopharmaceutical industry, including nearly a decade with Eli Lilly and Company.

Rivals

Competitors/colleagues of Dominick C. Colangelo

Holdings

See how much did Dominick C. Colangelo make over time.

Dominick C. Colangelo's holdings in Vericel Corporation are notable. His stock options reflect a significant investment in the company’s future. In 2018 alone, he was granted 300,000 stock options, emphasizing alignment with shareholder interests. These options, granted at $7.20 per...

Dominick C. Colangelo's holdings in Vericel Corporation are notable. His stock options reflect a significant investment in the company’s future. In 2018 alone, he was granted 300,000 stock options, emphasizing alignment with shareholder interests. These options, granted at $7.20 per share, could be a lucrative asset if the stock price performs well. In past years, his holdings have seen fluctuations, with peak values tied to his earlier options granted in 2013, when he had over 55,000 shares vesting, demonstrating both risk and potential during his tenure. As of early 2019, the value of his exercised options exceeded $2 million, indicating his proactive approach has been fruitful. Colangelo has consistently placed substantial value in company stock, showcasing his commitment to Vericel's mission.

Loading...

Total Stock Sold

$29.70M

VCEL

$29.70M

803,798 VCEL shares

What if they kept their stock?

If Dominick C. Colangelo didn't sell their stock, today they would have:
Extra VCEL803,798 shares worth $13.02M.
This is -56.15% and $16.68M less than what they got when they sold the stock.

Charitable Transactions

VCEL

6,757 shares

VCEL

Recent Charitable Transactions

VCEL

6,757 shares

VCEL

Dec 13, 2023

Charity

Insider Trading

See recent insider trades of Dominick C. Colangelo.

VCEL

$1.92M

VCEL at $54.75/share

Nov 13, 2024

Sale

VCEL

$1.43M

VCEL at $40.86/share

Oct 16, 2024

Sale

VCEL

$1.53M

VCEL at $43.64/share

Sep 11, 2024

Sale

VCEL

$1.60M

VCEL at $45.71/share

Aug 14, 2024

Sale

VCEL

$1.80M

VCEL at $51.47/share

Jul 17, 2024

Sale

VCEL

$1.53M

VCEL at $43.61/share

Jun 12, 2024

Sale

VCEL

$1.71M

VCEL at $48.76/share

May 15, 2024

Sale

VCEL

$1.59M

VCEL at $45.53/share

Apr 17, 2024

Sale

VCEL

$1.55M

VCEL at $44.35/share

Mar 13, 2024

Sale

VCEL

$1.68M

VCEL at $47.92/share

Feb 14, 2024

Sale

Compensation History

See how much did Dominick C. Colangelo make over time.

In 2018, Dominick C. Colangelo's total compensation reached approximately $2.6 million, which included a base salary of $592,000 and bonuses driven by impressive company performance. His bonus structure reflects a focus on results, rewarding him with up to 130% of the target amount due to Vericel exceeding revenue goals. This pay-for-performance model aligns his earnings with the company's success, ensuring that his financial gains are tied directly to the health of the business. His compensation package also includes long-term incentives to further solidify his stake in Vericel’s innovative endeavors. Despite fluctuations in prior years, his recent compensation trend signals a positive outlook for both him and the company going forward.

Year

2014

Total Compensation

$706.13K

Salary

$430.00K

Board Justification

The compensation program aims to attract, retain, and motivate talented executives, aligning their interests with those of shareholders through a pay-for-performance approach.

Bonus

$236.50K

Board Justification

The bonus awarded was based on the achievement of corporate and individual performance goals during the year, with a target incentive of 50% of base salary.

Other

$39.63K

Board Justification

Includes contributions to the 401(k) Plan and reimbursable commuting expenses.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock was reported as vested in 2014.

Performance Metrics

The performance metrics included achieving corporate objectives such as raising capital and expanding the product portfolio.